WO2003016266A1 - Composes $g(b)-cetoamides et leur utilisation medicinale - Google Patents
Composes $g(b)-cetoamides et leur utilisation medicinale Download PDFInfo
- Publication number
- WO2003016266A1 WO2003016266A1 PCT/JP2002/008211 JP0208211W WO03016266A1 WO 2003016266 A1 WO2003016266 A1 WO 2003016266A1 JP 0208211 W JP0208211 W JP 0208211W WO 03016266 A1 WO03016266 A1 WO 03016266A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- hiv agents
- hiv
- inhibitory activity
- integrase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/80—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms having carbon atoms of carboxamide groups and keto groups bound to the same carbon atom, e.g. acetoacetamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001247346 | 2001-08-16 | ||
JP2001-247346 | 2001-08-16 | ||
JP2001372066 | 2001-12-05 | ||
JP2001-372066 | 2001-12-05 | ||
JP2002-151232 | 2002-05-24 | ||
JP2002151232 | 2002-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003016266A1 true WO2003016266A1 (fr) | 2003-02-27 |
Family
ID=27347336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/008211 WO2003016266A1 (fr) | 2001-08-16 | 2002-08-12 | Composes $g(b)-cetoamides et leur utilisation medicinale |
Country Status (2)
Country | Link |
---|---|
PE (1) | PE20030434A1 (fr) |
WO (1) | WO2003016266A1 (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006520759A (ja) * | 2003-03-21 | 2006-09-14 | ハー・ルンドベック・アクチエゼルスカベット | 置換されたp−ジアミノベンゼン誘導体 |
US7109186B2 (en) | 2002-07-09 | 2006-09-19 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US7211572B2 (en) | 2003-08-13 | 2007-05-01 | Japan Tobacco Inc. | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
US7820818B2 (en) | 2002-08-30 | 2010-10-26 | Novartis Ag | Heteroaryl nitrile derivatives |
US8609717B2 (en) | 2010-08-18 | 2013-12-17 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activators |
US9533976B2 (en) | 2013-02-22 | 2017-01-03 | Samumed, Llc | γ-diketones as WNT/β-catenin signaling pathway activators |
US9795550B2 (en) | 2014-08-20 | 2017-10-24 | Samumed, Llc | Gamma-diketones for treatment and prevention of aging skin and wrinkles |
EP2344456B1 (fr) * | 2008-08-29 | 2018-07-25 | Japan Tobacco Inc. | Nouveau bloquant du canal potassique |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07267903A (ja) * | 1994-03-31 | 1995-10-17 | Nagase & Co Ltd | 抗hiv活性を有するフッ素含有化合物 |
WO1999062520A1 (fr) * | 1998-06-03 | 1999-12-09 | Merck & Co., Inc. | Inhibiteurs de vih integrase |
WO2001096283A2 (fr) * | 2000-06-16 | 2001-12-20 | Bristol-Myers Squibb Company | Inhibiteurs d'integrase du vih |
-
2002
- 2002-08-12 WO PCT/JP2002/008211 patent/WO2003016266A1/fr active Application Filing
- 2002-08-15 PE PE2002000740A patent/PE20030434A1/es not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07267903A (ja) * | 1994-03-31 | 1995-10-17 | Nagase & Co Ltd | 抗hiv活性を有するフッ素含有化合物 |
WO1999062520A1 (fr) * | 1998-06-03 | 1999-12-09 | Merck & Co., Inc. | Inhibiteurs de vih integrase |
WO2001096283A2 (fr) * | 2000-06-16 | 2001-12-20 | Bristol-Myers Squibb Company | Inhibiteurs d'integrase du vih |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7109186B2 (en) | 2002-07-09 | 2006-09-19 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
US7820818B2 (en) | 2002-08-30 | 2010-10-26 | Novartis Ag | Heteroaryl nitrile derivatives |
JP2006520759A (ja) * | 2003-03-21 | 2006-09-14 | ハー・ルンドベック・アクチエゼルスカベット | 置換されたp−ジアミノベンゼン誘導体 |
US7906537B2 (en) | 2003-03-21 | 2011-03-15 | H. Lundbeck A/S | Substituted p-diaminobenzene derivatives |
US7211572B2 (en) | 2003-08-13 | 2007-05-01 | Japan Tobacco Inc. | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
EP2042502A1 (fr) | 2003-08-13 | 2009-04-01 | Japan Tobacco Inc. | Composé cyclique fondu contenant de l'azote et son utilisation en tant qu'inhibiteur de l'intégrase du VIH |
EP2344456B1 (fr) * | 2008-08-29 | 2018-07-25 | Japan Tobacco Inc. | Nouveau bloquant du canal potassique |
US8609717B2 (en) | 2010-08-18 | 2013-12-17 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activators |
US8921413B2 (en) | 2010-08-18 | 2014-12-30 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators |
US9303010B2 (en) | 2010-08-18 | 2016-04-05 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators |
US9493437B2 (en) | 2010-08-18 | 2016-11-15 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activators |
US8629176B1 (en) | 2010-08-18 | 2014-01-14 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators |
US10314832B2 (en) | 2010-08-18 | 2019-06-11 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators |
US9884053B2 (en) | 2010-08-18 | 2018-02-06 | Samumed, Llc | β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activators |
US9533976B2 (en) | 2013-02-22 | 2017-01-03 | Samumed, Llc | γ-diketones as WNT/β-catenin signaling pathway activators |
US9951053B2 (en) | 2013-02-22 | 2018-04-24 | Samumed, Llc | γ-diketones as Wnt/β-catenin signaling pathway activators |
US10457672B2 (en) | 2013-02-22 | 2019-10-29 | Samumed, Llc | γ-diketones as Wnt/β-catenin signaling pathway activators |
US11034682B2 (en) | 2013-02-22 | 2021-06-15 | Samumed, Llc | Gamma-diketones as wnt/β-catenin signaling pathway activators |
US11673885B2 (en) | 2013-02-22 | 2023-06-13 | Biosplice Therapeutics, Inc. | γ-diketones as Wnt/β-catenin signaling pathway activators |
US9795550B2 (en) | 2014-08-20 | 2017-10-24 | Samumed, Llc | Gamma-diketones for treatment and prevention of aging skin and wrinkles |
US10434052B2 (en) | 2014-08-20 | 2019-10-08 | Samumed, Llc | Gamma-diketones for treatment and prevention of aging skin and wrinkles |
US11077046B2 (en) | 2014-08-20 | 2021-08-03 | Biosplice Therapeutics, Inc. | Gamma-diketones for treatment and prevention of aging skin and wrinkles |
US11839679B2 (en) | 2014-08-20 | 2023-12-12 | Biosplice Therapeutics, Inc. | Gamma-diketones for treatment and prevention of aging skin and wrinkles |
Also Published As
Publication number | Publication date |
---|---|
PE20030434A1 (es) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1564210A4 (fr) | Composes 4-oxoquinoliniques et leur utilisation comme inhibiteur de la vih-integrase | |
TW200510425A (en) | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor | |
EP2033954A4 (fr) | Composé 6-(benzyle substituté par hétérocycle)-4-oxoquinoline et utilisation de celui-ci comme inhibiteur de l'intégrase du vih | |
AU2003292437A1 (en) | Tetrahydro-4h-pyrido(1,2-a)pyrimidines and related compounds useful as hiv integrase inhibitors | |
IN2012DN06436A (fr) | ||
BR0213522A (pt) | Composto, composição farmacêutica, métodos de inibir a hiv integrase e para prevenir ou tratar a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids em um paciente, e, combinação útil para tratar ou prevenir a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids | |
DK1441734T3 (da) | Dihydroxypyrimidin-carboxamid-inhibitorer a HIV-integrase | |
PT871465E (pt) | Utilizacao de ritonavir (abt-538) para melhorar a farmacocinetica de drogas metabolizadas por citocromo p450 num metodo de tratamento da sida | |
WO2003000343A3 (fr) | Administration d'inhibiteurs de phosphodiesterase destinee au traitement de l'ejaculation precoce | |
WO2005120516A3 (fr) | Inhibiteurs intégrase vih | |
HUP0400553A2 (hu) | Gyógyászati készítmények | |
WO2003016266A1 (fr) | Composes $g(b)-cetoamides et leur utilisation medicinale | |
WO2002000166A3 (fr) | Nouveaux composes utiles comme agents antibacteriens | |
HUP0103819A2 (hu) | Kristályos efavirenz, azt hatóanyagként tartalmazó gyógyszerkészítmények, valamint az efavirenz alkalmazása a HIV reverz transzkriptáz gátlására és a HIV-fertőzések kezelésére alkalmas gyógyszerkészítmény előállítására | |
CA2417935A1 (fr) | Medicament anti-inflammatoire | |
WO2005115147A3 (fr) | Inhibiteurs de la transcriptase inverse du vih | |
WO2004047725A3 (fr) | Composes de 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine utilises comme inhibiteurs de l'integrase du vih | |
WO2002009717A1 (fr) | Remedes contre la dyserection contenant des derives de prostaglandine comme principe actif | |
AU2001267561A1 (en) | Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents | |
WO2003024941A1 (fr) | Composes de naphtalene et leur utilisation comme medicament | |
EA199700150A1 (ru) | КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ ПО ПОВОДУ ВИЧ ИНФЕКЦИИ С ИСПОЛЬЗОВАНИЕМ ИНГИБИТОРА ПРОТЕАЗЫ ВИЧ ИНДИНАВИРА И ИНГИБИТОРА ОБРАТНОЙ ТРАНСКРИПТАЗЫ 3TC, НЕОБЯЗАТЕЛЬНО СОВМЕСТНО С AZT, ddI ИЛИ ddC | |
WO2002000168A3 (fr) | Traitement combine anti-vih comprenant de la camptothecine | |
EP1411956B8 (fr) | Utilisation de polysaccharides sursulfates comme inhibiteurs du hiv | |
WO2001070216A3 (fr) | Composes possedant une activite anti vih | |
WO1996041634A3 (fr) | Utilisation d'un inhibiteur de transcriptase inverse non-nucleosidique en association avec des inhibiteurs de nucleosides pour le traitement d'infections a vih |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS KE KG KR KZ LC LR LS LT LU LV MA MD MG MK MN MX MZ NO NZ OM PH PL PT RO RU SE SG SI SK SL TJ TM TN TR TT TZ UG US UZ VC VN YU ZA ZM Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |